血管内皮生长因子D在肺腺癌免疫治疗反应中的作用

Xiaoling Du1,2, Sha Yang1, Jiaojiao Bian1

  • 1Department of Pharmacy, North Sichuan Medical College Nanchong 637000, Sichuan, P. R. China.

概括

血管内皮生长因子D (VEGFD) 与先天性免疫有关,并预测肺腺癌 (LUAD) 的预后. 在LUAD患者中,VEGFD还可以预测抗PD-1免疫疗法的反应.

相关概念视频

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K